DC591017, a phosphodiesterase-4 (PDE4) inhibitor with robust anti-inflammation through regulating PKA-CREB signaling.
第一作者:
Heng,Li
第一单位:
Laboratory of Anti-inflammation and Immunopharmacology, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China; School of Pharmacy, University of Chinese Academy of Sciences, Beijing 100049, China.
作者:
主题词
动物(Animals);消炎药(Anti-Inflammatory Agents);细胞, 培养的(Cells, Cultured);cAMP反应元件结合蛋白质(Cyclic AMP Response Element-Binding Protein);环AMP依赖性蛋白激酶类(Cyclic AMP-Dependent Protein Kinases);环核苷酸磷酸二酯酶类, 4型(Cyclic Nucleotide Phosphodiesterases, Type 4);女(雌)性(Female);人类(Humans);男(雄)性(Male);小鼠(Mice);小鼠, 近交BALB C(Mice, Inbred BALB C);小鼠, 近交C57BL(Mice, Inbred C57BL);分子结构(Molecular Structure);磷酸二酯酶4抑制剂(Phosphodiesterase 4 Inhibitors);银屑病(Psoriasis);大鼠, Sprague-Dawley(Rats, Sprague-Dawley);信号传导(Signal Transduction)
DOI
10.1016/j.bcp.2020.113958
PMID
32251674
发布时间
2020-12-23
- 浏览0
Biochemical pharmacology
113958页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文